One of the most pressing biomedical issues is the development of techniques that increase the efficiency of vaccines. In a paper published on April 24, 2008 in the journal Vaccine, a Massachusetts’s biotechnology company, Cure Lab, Inc. has proposed a new technology for anti-viral vaccination.

How is virus as for example HIV and bird flu able to make the cells within a human body work for the purpose of the virus? Researchers at the University of Copenhagen shed new light on this question.